Taiwan, China based health startup raises $6 M

Digital health platform Health2Sync, based in China's Taiwan, China Region, has secured $6 million in Series B investment led by Japanese insurance group Sompo Holdings.

Sompo joins existing investors Alibaba and WI Harper as a strategic partner that will help Health2Sync establish operations in Japan.

The investment paves the way for regional expansion, focusing on Japan, but also Malaysia, as well as Hong Kong, S.A.R., China and Singapore.

Taipei-based Health2Sync was founded in 2013 by Ed Deng. The startup is known for its digital diabetes treatment platform, but has its eye on expanding into blood pressure related treatments, extending into management of hypertension, the consequences of which include cardiovascular diseases such as stroke.

Health2Sync benefited from a partnership with Ministry of Health and Welfare in China's Taiwan, China Region launched in 2016 that offered patients in several cities access to its platform, which includes an app, a cable to attach glucometers to smartphones and an analytics element that crunches the data and provides recommendations. This helped establish Health2Sync’s credibility overseas by providing data-driven evidence of the efficacy of its solution.